- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Metastatic Prostate Adenocarcinoma
Total 23003 results
-
Astellas Pharma Global Development, Inc.Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedMetastatic Castration-Resistant Prostate CancerUnited States
-
National Cancer Institute (NCI)CompletedProstate Cancer | Metastatic Castrate Resistant Prostate CancerUnited States
-
Astellas Pharma Global Development, Inc.Medivation, Inc.Approved for marketingMetastatic Castration-Resistant Prostate Cancer
-
Duke UniversityUnited States Department of DefenseCompletedMetastatic Hormone Refractory Prostate CancerUnited States
-
Massachusetts General HospitalBayerCompletedProstate Cancer | Castration-resistant Prostate Cancer | Castration-resistant Prostate Cancer Metastatic to BoneUnited States
-
National Cancer Institute (NCI)TerminatedAdenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedCastration Resistant Prostate Cancer | Prostate Carcinoma Metastatic to the BoneUnited States
-
National Cancer Institute (NCI)CompletedStage I Prostate Adenocarcinoma AJCC v7 | Stage II Prostate Adenocarcinoma AJCC v7United States
-
Suzhou Kintor Pharmaceutical Inc,CompletedMetastatic Hormone-Sensitive Prostate Cancer (mHSPC) | Metastatic Castrate Resistant Prostate Cancer (mCRPC)United States
-
Case Comprehensive Cancer CenterCompletedAdenocarcinoma of the ProstateUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedStage III Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate Cancer | Stage IIB Prostate CancerUnited States
-
National Cancer Institute (NCI)CompletedProstate Adenocarcinoma | Recurrent Prostate Carcinoma | Stage IV Prostate Cancer | Hormone-Resistant Prostate CancerUnited States
-
Roswell Park Cancer InstituteMerck Sharp & Dohme LLCTerminatedRecurrent Prostate Cancer | Prostate Cancer | Hormone-resistant Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
Barbara Ann Karmanos Cancer InstituteCompletedRecurrent Prostate Cancer | Hormone-resistant Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
University of California, IrvineBristol-Myers SquibbCompletedRecurrent Prostate Cancer | Prostate Cancer | Hormone-resistant Prostate Cancer | Adenocarcinoma of the Prostate | Hormone-refractory Prostate CancerUnited States
-
OHSU Knight Cancer InstituteNational Cancer Institute (NCI)TerminatedRecurrent Prostate Cancer | Hormone-resistant Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Hormone-resistant Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Hormone-resistant Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Hormone-resistant Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
German Oncology Center, CyprusActive, not recruitingProstate Adenocarcinoma | Radiation ToxicityCyprus
-
University of MiamiCompletedProstate Cancer | Prostate Adenocarcinoma | Radiation ToxicityUnited States
-
Eli Lilly and CompanyCompletedAdenocarcinoma of the ProstateUnited States
-
Dana-Farber Cancer InstituteCompletedProstate Cancer | Adenocarcinoma of the ProstateUnited States
-
Mary-Ellen Taplin, MDSanofi; Beth Israel Deaconess Medical Center; Genentech, Inc.; Duke UniversityCompletedProstate Cancer | Adenocarcinoma of the ProstateUnited States
-
AstraZenecaNo longer availableAdenocarcinoma of the Prostate
-
Universität des SaarlandesRecruitingProstate Cancer Metastatic | Advanced Prostate Carcinoma | Castration Resistant Prostatic CancerGermany
-
University Health Network, TorontoCompletedProstate Cancer (Adenocarcinoma)Canada
-
Xinhua Hospital, Shanghai Jiao Tong University...UnknownProstate Cancer Recurrent | Prostate Cancer Metastatic | Prostate Cancer (Diagnosis) | Prostate Cancer StageChina
-
OHSU Knight Cancer InstituteBristol-Myers Squibb; Oregon Health and Science UniversityCompletedRecurrent Prostate Cancer | Hormone-resistant Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Hormone-resistant Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Millennium: The Takeda Oncology CompanyCompletedRecurrent Prostate Cancer | Hormone-resistant Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI); Millennium Pharmaceuticals, Inc.TerminatedRecurrent Prostate Cancer | Hormone-resistant Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
NanOlogy, LLCUS Biotest, Inc.CompletedAdenocarcinoma of the ProstateUnited States
-
Medical University of South CarolinaNational Cancer Institute (NCI)Completed
-
OHSU Knight Cancer InstitutePfizerTerminatedProstate Cancer | Adenocarcinoma of the ProstateUnited States
-
Massachusetts General HospitalDana-Farber Cancer InstituteCompletedProstate Cancer | Adenocarcinoma of the ProstateUnited States
-
Ignacio Puche SanzChinese University of Hong Kong; UMC Utrecht; University of Padova; Medical University... and other collaboratorsNot yet recruitingProstate Cancer MetastaticSpain
-
BayerOrion Corporation, Orion PharmaCompletedProstate Cancer Non-Metastatic | Castration-ResistantBelgium, France, Poland, Spain, Canada, United States, Estonia, Portugal, Taiwan, Japan, Russian Federation, Finland, Germany, Austria, Czechia, Hungary, Australia, Brazil, South Africa, Latvia, Italy, United Kingdom, Turkey, Serbia, Ro... and more
-
BayerCompletedMetastatic Castration-resistant Prostate Cancer (mCRPC)United States
-
Jonsson Comprehensive Cancer CenterNovartisNo longer availableProgressive Metastatic Castrate Resistant Prostate Cancer
-
UMC UtrechtRadboud University Medical Center; Universitaire Ziekenhuizen KU Leuven; The...CompletedProstate Cancer AdenocarcinomaNetherlands, Belgium
-
University of WashingtonNational Cancer Institute (NCI)CompletedCastration-Resistant Prostate Carcinoma | Metastatic Prostate Carcinoma | Stage IV Prostate Cancer | PSA Progression | Castration Levels of Testosterone | Prostate Carcinoma Metastatic in the BoneUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
Chang Gung Memorial HospitalRecruiting
-
Peking Union Medical College HospitalNational Institute for Biomedical Imaging and Bioengineering (NIBIB)RecruitingMetastatic Castration-resistant Prostate CancerChina
-
Allife Medical Science and Technology Co., Ltd.Tianjin People's HospitalRecruitingMetastatic Castration-resistant Prostate CancerChina
-
Exosome Diagnostics, Inc.Yale UniversitySuspendedMetastatic Castrate Resistant Prostate CancerUnited States
-
Jiangsu HengRui Medicine Co., Ltd.Active, not recruitingMetastatic Castration Resistant Prostate CancerChina
-
Dizal PharmaceuticalsTerminatedMetastatic Castration Resistant Prostate CancerUnited States, Korea, Republic of
-
Royal North Shore HospitalTerminatedMetastatic Castrate- Resistant Prostate CancerAustralia